MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2016 International Congress

June 19-23, 2016. Berlin, Germany.

View by Title View Sessions
View by Date

Monday, June 20, 2016

12:30pm-2:00pm
My PD Journey: Experiences reported by people with Parkinson’s disease in several European countries – A quantitative and qualitative study

A. Schrag, O. Rascol, R. Merritt, S. Hotham, G. Bartl, L. Graham, On behalf of the European Parkinson's Disease Association (EPDA) and the Movement Disorder Society- European Section European Section (London, United Kingdom)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Neurocognitive domains of impulsivity in Parkinson’s disease (PD) and the effects of dopaminergic replacement therapy (DRT)

M. Sousa, N. Canário, F. Moreira, C. Duarte, M. Castelo-Branco, C. Januário (Coimbra, Portugal)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Neurophysiological assessment of corticospinal tract activation due to subthalamic deep brain stimulation in patients with Parkinson’s disease

P. Mahlknecht, H. Akram, D. Georgiev, J. Candelario, A. Zacharia, Z. Kefalopoulou, L. Zrinzo, J. Hyam, M. Hariz, C. Milabo, T. Foltynie, J.C. Rothwell, P. Limousin (Innsbruck, Austria)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Neuropsychiatric disturbances in Parkinson’s disease patients’ with chronic pain

G. Pavlic, I. Moldovanu, N. Diaconu, L. Rotaru (Chisinau, Republic of Moldova)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Neuropsychological assessment in the Luxembourg Parkinson’s cohort (HELP-PD)

G. Hipp, P. Kolber, K. Roomp, M. Kerschenmeyer, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Schneider, R. Balling, N.J. Diederich, R. Krüger (Belvaux, Luxembourg)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Neuropsychological safety of bilateral pallidal (GPi) deep brain stimulation (DBS) for Parkinson’s disease (PD) under general anesthesia

A.I. Tröster, F.A. Ponce, L. Autry, M. Lambert, V.G. Evidente, S. Oravivattanakul, A. Lieberman, G. Moguel-Cobos, N. Salins, K. Hanson (Phoenix, AZ, USA)

Surgical therapy: Parkinson's disease  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Nighttime sleep problems in patients with Parkinson’s disease: Risk factors and longitudinal associations

K. Zhu, J.J. van Hilten, J. Marinus (Leiden, Netherlands)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Non motor symptoms burden and motor staging of Parkinson’s disease: Evidence for dichotomy and non-motor dominant subtypes from analysis of 249 cases

K. Ray Chaudhuri, A. Sauerbier, T. Thavayogarajah, A. Rizos, L. Perkins, C. Rodriguez Blazquez, P. Martinez-Martin, On behalf of EUROPAR, the MDS Non-Motor PD Study Group, The NILS Group (London, United Kingdom)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Non motor symptoms of Parkinson’s disease: Prevalence and impact on quality of life

M. Chraa, K. Choulli, N. Kissani (Marrakech, Morocco)

Parkinson's disease: Non-motor symptoms  ·  Exhibit Hall located in Hall B, Level 2
12:30pm-2:00pm
Non-contact boxing in Parkinson’s disease

Z.R. Yee, S.H.X. Liew (Singapore, Singapore)

Quality of life/caregiver burden in movement disorders  ·  Exhibit Hall located in Hall B, Level 2
  • «Previous Page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • …
  • 53
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Patients with Essential Tremor Live Longer than their Relatives
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley